Traders Purchase Large Volume of Call Options on UnitedHealth Group (NYSE:UNH)

UnitedHealth Group Incorporated (NYSE:UNH) was the target of some unusual options trading activity on Wednesday. Traders purchased 164,087 call options on the stock. This is an increase of approximately 30% compared to the typical volume of 125,857 call options.

Trending Headlines about UnitedHealth Group

Here are the key news stories impacting UnitedHealth Group this week:

• Positive Sentiment: Q1 beat and guidance lift — UNH reported stronger‑than‑expected Q1 results (EPS beat and revenue above estimates) and raised FY‑2026 adjusted EPS guidance to above $18.25, which is the primary catalyst for the rally. Business Wire: Q1 Results
• Positive Sentiment: Wall Street upgrades and price‑target increases — Multiple firms (Morgan Stanley, RBC, Oppenheimer, Wells Fargo, Barclays, Argus, Jefferies and others) raised ratings/targets after the quarter, adding buying momentum and supporting forward valuation. Benzinga: Analysts Increase Forecasts
• Positive Sentiment: AI and operational initiatives highlighted — Management flagged a sizable AI investment (about $1.5B) and rapid scale-up of Optum Real (high‑throughput claims/reimbursement platform), which investors view as structural drivers for efficiency and margin recovery. PYMNTS: UNH AI/Optum Real
• Neutral Sentiment: Sector ripple — UNH’s stronger print lifted other insurers (CVS, Humana, Molina, Centene) as investors re‑price Medicare Advantage and managed‑care exposure; this is sentiment flow rather than company‑specific news. Yahoo: Sector Impact
• Neutral Sentiment: Earnings call detail available — Transcript/highlights show management focused on margin discipline and restructuring; useful for modeling but not an immediate price driver beyond the beat-and-raise. Seeking Alpha: Earnings Call Transcript
• Negative Sentiment: Policy/program uncertainty — UnitedHealth flagged challenges around a Medicare pilot to cover obesity drugs, creating execution and reimbursement uncertainty that could affect future medical cost trends. Reuters: Medicare Obesity Drug Pilot
• Negative Sentiment: Medical‑cost and execution risk persist — While Q1 showed easing, management and analysts still warn that medical‑cost volatility and prior year operational issues remain risks to sustaining margin recovery; a minority of analysts remain cautious. Reuters: Q1 Profit & Risks

Institutional Investors Weigh In On UnitedHealth Group

A number of institutional investors and hedge funds have recently modified their holdings of the company. Norges Bank purchased a new stake in UnitedHealth Group in the fourth quarter valued at approximately $4,376,167,000. Capital Research Global Investors raised its stake in UnitedHealth Group by 126.9% in the third quarter. Capital Research Global Investors now owns 13,042,049 shares of the healthcare conglomerate’s stock valued at $4,503,419,000 after purchasing an additional 7,293,009 shares in the last quarter. Capital World Investors raised its stake in UnitedHealth Group by 18.8% in the third quarter. Capital World Investors now owns 21,766,922 shares of the healthcare conglomerate’s stock valued at $7,516,107,000 after purchasing an additional 3,439,182 shares in the last quarter. T. Rowe Price Investment Management Inc. raised its stake in UnitedHealth Group by 141.9% in the fourth quarter. T. Rowe Price Investment Management Inc. now owns 4,109,029 shares of the healthcare conglomerate’s stock valued at $1,356,432,000 after purchasing an additional 2,410,128 shares in the last quarter. Finally, Cardano Risk Management B.V. raised its stake in UnitedHealth Group by 864.4% in the fourth quarter. Cardano Risk Management B.V. now owns 2,523,700 shares of the healthcare conglomerate’s stock valued at $833,099,000 after purchasing an additional 2,262,006 shares in the last quarter. 87.86% of the stock is owned by hedge funds and other institutional investors.

UnitedHealth Group Stock Performance

NYSE:UNH traded up $7.50 on Wednesday, reaching $353.51. 11,791,623 shares of the company’s stock were exchanged, compared to its average volume of 9,748,933. UnitedHealth Group has a 52 week low of $234.60 and a 52 week high of $438.85. The firm has a market cap of $320.88 billion, a price-to-earnings ratio of 26.80, a P/E/G ratio of 1.49 and a beta of 0.40. The company has a debt-to-equity ratio of 0.72, a current ratio of 0.79 and a quick ratio of 0.79. The stock has a fifty day simple moving average of $289.27 and a 200-day simple moving average of $316.84.

UnitedHealth Group (NYSE:UNH) last announced its quarterly earnings results on Tuesday, April 21st. The healthcare conglomerate reported $7.23 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $6.76 by $0.47. UnitedHealth Group had a net margin of 2.69% and a return on equity of 14.79%. The firm had revenue of $111.65 billion for the quarter, compared to the consensus estimate of $109.84 billion. During the same period in the prior year, the firm posted $7.20 earnings per share. The company’s revenue for the quarter was up 2.0% on a year-over-year basis. UnitedHealth Group has set its FY 2026 guidance at 18.250- EPS. As a group, sell-side analysts predict that UnitedHealth Group will post 17.66 earnings per share for the current year.

UnitedHealth Group Dividend Announcement

The company also recently declared a quarterly dividend, which was paid on Tuesday, March 17th. Stockholders of record on Monday, March 9th were issued a $2.21 dividend. This represents a $8.84 dividend on an annualized basis and a dividend yield of 2.5%. The ex-dividend date of this dividend was Monday, March 9th. UnitedHealth Group’s dividend payout ratio is presently 67.02%.

Analyst Ratings Changes

A number of analysts have commented on the stock. KeyCorp restated an “overweight” rating on shares of UnitedHealth Group in a research note on Wednesday, January 28th. Jefferies Financial Group boosted their price target on shares of UnitedHealth Group from $340.00 to $373.00 and gave the stock a “buy” rating in a report on Monday. UBS Group lowered their price objective on UnitedHealth Group from $430.00 to $410.00 and set a “buy” rating on the stock in a research note on Wednesday, January 28th. Royal Bank Of Canada increased their target price on shares of UnitedHealth Group from $361.00 to $400.00 and gave the stock an “outperform” rating in a research report on Wednesday. Finally, Mizuho cut their target price on shares of UnitedHealth Group from $430.00 to $350.00 and set an “outperform” rating for the company in a research report on Thursday, February 5th. One research analyst has rated the stock with a Strong Buy rating, nineteen have given a Buy rating, seven have given a Hold rating and two have assigned a Sell rating to the stock. According to MarketBeat, UnitedHealth Group presently has an average rating of “Moderate Buy” and an average price target of $377.68.

About UnitedHealth Group

UnitedHealth Group Inc is a diversified health care company headquartered in Minnetonka, Minnesota, that operates two primary business platforms: UnitedHealthcare and Optum. Founded in 1977, the company provides a broad range of health benefits and health care services to individuals, employers, governmental entities and other organizations. Its operations span commercial employer-sponsored plans, individual and Medicare and Medicaid programs, and services for customers and health systems in the United States and selected international markets.

UnitedHealthcare is the company’s benefits business, administering health plans and networks, managing provider relationships, and offering coverage products for employers, individuals, and government-sponsored programs.